Finanziato dall’Unione Europea - NextGenerationEU
    MUR PNRR    PNRR Italia Domani

(<b style=color:#FF0000>SCADUTO</b>) Cascade Open Call 2023 for Research Node 4 - NETWORK FOR IDENTIFICATION OF CLINICAL AND DIAGNOSTIC MARKERS OF DISEASE SEVERITY/OUTCOME AND IMMUNOLOGICAL MONITORING: A. ADULTS, B. CHILDREN, C. INTENSIVE CARE

(SCADUTO) Cascade Open Call 2023 for Research Node 4 - NETWORK FOR IDENTIFICATION OF CLINICAL AND DIAGNOSTIC MARKERS OF DISEASE SEVERITY/OUTCOME AND IMMUNOLOGICAL MONITORING: A. ADULTS, B. CHILDREN, C. INTENSIVE CARE

(SCADUTO) Cascade Open Call 2023 for Research Node 4 - NETWORK FOR IDENTIFICATION OF CLINICAL AND DIAGNOSTIC MARKERS OF DISEASE SEVERITY/OUTCOME AND IMMUNOLOGICAL MONITORING: A. ADULTS, B. CHILDREN, C. INTENSIVE CARE


This call has been published by Spoke 4: Istituto Superiore di Sanità. - The available budget for this call is of EUR 5'000'000.00.
Support during collection of Applications and Evaluations is provided by the INF-ACT Foundation.




CALL DESCRIPTION AND OBJECTIVES

Clinical monitoring of severity of emerging infections and response to treatment is a challenging task. Target patient populations are people hosted in adult and paediatric infectious disease wards as well as those in intensive care units due to diseases caused by emerging pathogens targeted by the INF-ACT project. Partner institutions of the call should, overall, be able to constitute networks able to gather data from the three target patient populations.


Projects responding to this call should aim to expand a national multisectorial network to identify clinical/diagnostic/immunological parameters that are indicative of disease severity/outcome.


Expected Results: Improvement, through the analysis of the association between clinical/immunological/microbiological markers, the characterization of recognizable disease profiles for more personalized approaches to clinical care.




ELIGIBILITY CRITERIA:




HOW TO APPLY


The call text (in Italian) has been published on the ISS website. -
Collection of applications started at 04:00 PM on Nov 10, 2023 - Deadline 12:00 PM on Dec 21, 2023

If you have questions or need more information about the application process, write to calls@inf-act.it.




FREQUENTLY-ASKED QUESTIONS


Frequently-asked questions (FAQs) are published here. Due to frequent updates, FAQs are published only in Italian. If translations are required, please send us a message to calls@inf-act.it. Check this page frequently.


Documentazione da Presentare
Soggetti Ammissibili
Durata del Progetto
Partnership con la Fondazione INF-ACT
Costi ammissibili e modalità di rendicontazione
Reclutamento personale a T.D. su fondi di progetto
Cofinanziamento
Quota 40% nel Mezzogiorno
Numero di progetti Finanziati



REPORTING AND OTHERS



EVALUATION PROCESS

Proposals will be evaluated on the basis of the following evaluation criteria:

Proposals will be considered admissible for financing if they obtain at least 70 out of 100 points. Evaluation will be carried out by a panel of 3-5 international and highly-qualified scientists, who are not directly involved in the INF-ACT Research Program. Reviewers will sign a declaration to exclude possible conflicts of interest before accessing the scientific proposals to be evaluated.




INF-ACT partner institutions involved: ISS


INF-ACT Research Nodes involved: RN4


Tags: Research, Grants, Cascade Open Calls

Last update: 11/10/2023


Back to previous page - List of INF-ACT Calls and Opportunities
 

INF-ACT è una Fondazione di Partecipazione)
Codice Fiscale 96084470184 - Partiva IVA 02894510185
Indirizzo: Corso Strada Nuova, 65 - 27100 Pavia (Italy)
Contatto e-mail: management@inf-act.it - PEC: inf-act@pec.it

Fondazione Trasparente - Privacy & Cookies


La Fondazione INF-ACT è soggetto Hub di un progetto finanziato attraverso il Piano Nazionale di Ripresa e Resilienza (PNRR), Missione 4 Componente 2 Investimento 1.3 - Avviso N. 341 del 15 marzo 2022 del Ministero dell’Università e della Ricerca finanziato dall’Unione Europea - NextGenerationEU; Codice Progetto PE00000007, Decreto di Agevolazione N. 1554 del 11 ottobre 2022 approvato dal Ministero dell’Università e della Ricerca, Titolo del Progetto "One Health Basic and Translational Actions Addressing Unmet Needs on Emerging Infectious Diseases (INF-ACT)".


Finanziato dall’Unione Europea - NextGenerationEU
    MUR PNRR    PNRR Italia Domani




Copyright 2023 INF-ACT Foundation - Tutti i diritti riservati

twitter:@fondaz_inf_act   linkedin:@fondazione-inf-act